Brock C - Search Results

1

Does the rapid response to cisplatin-based chemotherapy justify its use as primary treatment for intracranial germ-cell tumours?

Vijayaraghavan S, Brock C, Monson JP, Snodgrass GJ, King TT, Gallagher C, Oliver RT. Vijayaraghavan S, et al. Among authors: brock c. Q J Med. 1993 Dec;86(12):801-10. Q J Med. 1993. PMID: 7509079

2

POMB/ACE chemotherapy for mediastinal germ cell tumours.

Bower M, Brock C, Holden L, Nelstrop A, Makey AR, Rustin GJ, Newlands ES. Bower M, et al. Among authors: brock c. Eur J Cancer. 1997 May;33(6):838-42. doi: 10.1016/s0959-8049(96)00403-0. Eur J Cancer. 1997. PMID: 9291802

3

A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.

Bower M, Brock C, Gulliford T, O'Reilly SM, Smith DB, Newlands ES. Bower M, et al. Among authors: brock c. Cancer Chemother Pharmacol. 1996;38(1):106-9. doi: 10.1007/s002800050455. Cancer Chemother Pharmacol. 1996. PMID: 8603443 Clinical Trial.

4

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ, Begent RH, Bagshawe KD. Bower M, et al. Among authors: brock c. J Clin Oncol. 1997 Jul;15(7):2636-43. doi: 10.1200/JCO.1997.15.7.2636. J Clin Oncol. 1997. PMID: 9215835

5

Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas.

Brock CS, Young H, O'Reilly SM, Matthews J, Osman S, Evans H, Newlands ES, Price PM. Brock CS, et al. Br J Cancer. 2000 Feb;82(3):608-15. doi: 10.1054/bjoc.1999.0971. Br J Cancer. 2000. PMID: 10682673 Free PMC article. Clinical Trial.

6

The management of high-risk gestational trophoblastic tumours (GTT).

Newlands ES, Bower M, Holden L, Short D, Brock C, Rustin GJ, Begent RH, Bagshawe KD. Newlands ES, et al. Among authors: brock c. Int J Gynaecol Obstet. 1998 Apr;60 Suppl 1:S65-70. Int J Gynaecol Obstet. 1998. PMID: 9833617

7

The Charing Cross Hospital experience with temozolomide in patients with gliomas.

Newlands ES, O'Reilly SM, Glaser MG, Bower M, Evans H, Brock C, Brampton MH, Colquhoun I, Lewis P, Rice-Edwards JM, Illingworth RD, Richards PG. Newlands ES, et al. Among authors: brock c. Eur J Cancer. 1996 Dec;32A(13):2236-41. doi: 10.1016/s0959-8049(96)00258-4. Eur J Cancer. 1996. PMID: 9038604 Clinical Trial.

8

Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

Brock CS, Meikle SR, Price P. Brock CS, et al. Eur J Nucl Med. 1997 Jun;24(6):691-705. doi: 10.1007/BF00841411. Eur J Nucl Med. 1997. PMID: 9169580 Review.

9

Gestational choriocarcinoma.

Bower M, Brock C, Fisher RA, Newlands ES, Rustin GJ. Bower M, et al. Among authors: brock c. Ann Oncol. 1995 May;6(5):503-8. doi: 10.1093/oxfordjournals.annonc.a059222. Ann Oncol. 1995. PMID: 7669714 Free article. No abstract available.

10

Phase I trial of temozolomide using an extended continuous oral schedule.

Brock CS, Newlands ES, Wedge SR, Bower M, Evans H, Colquhoun I, Roddie M, Glaser M, Brampton MH, Rustin GJ. Brock CS, et al. Cancer Res. 1998 Oct 1;58(19):4363-7. Cancer Res. 1998. PMID: 9766665 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

508 results

Search Page

Filters